RTT - Canadian News
CAH Closer To FDA Approval, Another Alzheimer's Disease Drug Fails, VTVT Tanks
Wed, 13 Jun 2018 05:45:47 GMT
Today's Daily Dose brings you news about expanded FDA approval for Agilent's Dako PD-L1 IHC 22C3 pharmDx assay; Albireo Pharma's lead product candidate A4250 securing rare pediatric disease designation from the FDA for the treatment of progressive familial intrahepatic cholestasis; Cardinal Health's INCRAFTAAA Stent Graft System getting favorable FDA panel recommendation, among others.
GLMD Arrests Investor Attention, SAGE Excited, GEMP On Close Watch
Wed, 13 Jun 2018 01:43:32 GMT
The following are some of today's top gainers in the pharma/biotech sector.
BIIB's Alzheimer's Drug Scores Well, EXAS Heads Higher, VXRT Down But Not Out
Wed, 06 Jun 2018 05:02:45 GMT
Today's Daily Dose brings you news about Eisai/Biogen's phase II study of Elenbecestat in Alzheimer's disease; Exact Sciences' newly identified biomarker panel and Ironwood Pharma's updated data from phase IIb trial of IW-3718 in persistent gastroesophageal reflux disease, among others.
CODX Advances, LLIT Makes Smart Moves, EOLS Up Over 400% Since Beginning Of May
Wed, 06 Jun 2018 01:11:08 GMT
The following are some of today's top gainers in the pharma/biotech sector.
Patience Pays Off For Galmed Investors...
Tue, 12 Jun 2018 15:35:38 GMT
Shares of Galmed Pharmaceuticals Ltd. (GLMD) skyrocketed as much as 284% in early trade on Tuesday, and as of this writing are up over 180%, following encouraging top-line, 52-week results from its study dubbed ARREST.
EOLS Recovers, BLCM Awaits DATA, Time To Keep An Eye On RARX
Tue, 12 Jun 2018 00:13:13 GMT
The following are some of today's top gainers in the pharma/biotech sector.
Kudlow: Trump Prefers Separate Negotiations With Canada And Mexico
Tue, 05 Jun 2018 17:22:49 GMT
President Donald Trump would prefer to hold separate trade negotiations with Canada and Mexico, according to National Economic Council Director Larry Kudlow.
GHDX: In The Pink Of Health
Tue, 05 Jun 2018 14:04:23 GMT
Shares of Genomic Health Inc. (GHDX) touched an all-time high of $49.06 in early trade today.
Australian Dollar Declines After RBA Holds Fire On Rate
Tue, 05 Jun 2018 07:28:13 GMT
The Australian dollar slipped against its major counterparts in the Asian session on Tuesday, after the Reserve Bank of Australia left its key interest rate unchanged at a record low, where it has been since August 2016. The decision was in line with expectations.
FDA Approves First Neulasta Biosimilar, HQY Hits New High, TGTX Turns Heads
Tue, 05 Jun 2018 05:18:55 GMT
Today's Daily Dose brings you news about Cellectis' progress related to its CAR T-cell product candidate; HealthEquity's first-quarter results; FDA approval of the first biosimilar to Neulasta, and TG Therapeutics' encouraging updated clinical data from its ongoing Phase 2 study of Umbralisib in patients with relapsed or refractory Chronic Lymphocytic Leukemia.
DCPH Soars On ASCO Data, AVXL Braces For Busy Year, GHDX In Good Health
Tue, 05 Jun 2018 00:40:06 GMT
Deciphera Pharmaceuticals soared more than 47% on Monday, thanks to encouraging updated data from its ongoing Phase 1 clinical trial of DCC-2618 in patients with gastrointestinal stromal tumors (GIST) that were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Saturday.
Largest Ever Study Finds Early Risers Have Lower Risk Of Depression
Thu, 14 Jun 2018 23:02:22 GMT
In the largest study ever to analyse the possible link between chronotype and mood disorders, researchers have found that early risers are significantly less likely to develop depression.
This Day That Year: Athenex
Thu, 14 Jun 2018 07:02:04 GMT
Shares of Athenex Inc. (ATNX) have returned nearly 46% over the last 1 year while the iShares NASDAQ Biotechnology Index (ETF) has gained a mere 12% during the same period.
GALT Vaults As NASH Research Sparks Interest, MDGL Abuzz, MACK Awaits Data
Thu, 14 Jun 2018 00:32:43 GMT
The following are some of today's top gainers in the pharma/biotech sector.
IMGN Prices Upsized Offering, STRM Rises On Q1 Results, PTI Tanks After-Hours
Thu, 07 Jun 2018 05:38:26 GMT
Today's Daily Dose brings you news about ImmunoGen's stock offering; Ascendis securing Orphan Drug Designation for TransCon PTH; Streamline Health's strong quarterly results; FDA granting Rare Pediatric Disease Designation for Cellectar's CLR 131, and Proteostasis' phase I study results of PTI-801 in cystic fibrosis patients.
AXON Soars On Licensing Gene Therapy, HTBX Gains Momentum, TNXP Awaits Data
Thu, 07 Jun 2018 00:46:41 GMT
The following are some of today's top gainers in the pharma/biotech sector.
PolarityTE: Yes, It's Cool & Hot.
Sun, 10 Jun 2018 23:59:14 GMT
Shares of commercial-stage biotechnology and regenerative biomaterials company PolarityTE Inc (COOL) touched a new 52-week high of $33.22 on Friday. We had alerted our premium subscribers to this stock on April 30, 2018 (Report titled "Cool & Hot") when it was trading around $17.60.
An Ear To The Pharma: 9 Stocks To Watch (CTMX, ZEAL, MRSN...)
Sun, 03 Jun 2018 06:37:02 GMT
The week that went by saw major announcements related to non-alcoholic steatohepatitis, Duchenne Muscular Dystrophy and sickle cell disease. Now, here are some of the pharma/biotech stocks and upcoming events to keep an ear out for in the coming week.
An Ear To The Pharma: 5 Stocks To Watch (OBSV, GERN, SRPT.)
Sat, 16 Jun 2018 16:39:56 GMT
The week that went by saw NASH drug stocks back in focus as positive results from a phase II study of Galmed Pharmaceuticals Ltd.'s (GLMD) investigational drug Aramchol seems to have had a positive rub off impact. Aramchol is being developed for treatment of patients with biopsy proven non-alcoholic steatohepatitis, or NASH.
An Ear To The Pharma: 8 Stocks To Watch (CMRX, CRBP, KPTI, VRX.)
Sat, 09 Jun 2018 16:45:12 GMT
The week that went by saw a number of companies present updated results on their clinical trials at the American Society of Clinical Oncology (ASCO), the world's largest clinical cancer research meeting. Now, here are some of the pharma/biotech stocks and upcoming events to keep an ear out for in the coming week.
Will These Biotech Stocks Soar Or Slump This Month?
Mon, 11 Jun 2018 07:53:02 GMT
Clinical trial data is an important catalyst, and trial results or any update on the clinical studies can send the biotech stocks soaring or stumbling depending upon the news. Listed below are some of the biotech/pharma stocks awaiting clinical trial catalysts this month.
Thomson Reuters Appoints Brian Peccarelli & Neil Masterson As Co-COOs
Mon, 04 Jun 2018 10:42:06 GMT
Thomson Reuters (TRI, TRI.TO) announced the appointment of co-Chief Operating Officers, effective July 1. Brian Peccarelli (President, Tax & Accounting) has been named co-Chief Operating Officer with responsibility for Customer Markets. He will be responsible for all customer-facing operations including driving sales. Neil Masterson (Executive Vice President and Chief Transformation Officer) has been named co-Chief Operating Officer with responsibility for Operations & Enablement. Neil will manage commercial and technology operations.
FDA Nod For LLY/INCY RA Drug, JAZZ Hits Right Tones, SLS' Study Stopped Early
Mon, 04 Jun 2018 04:46:25 GMT
Today's Daily Dose brings you news about updated results from Celgene's TRANSCEND study; Epizyme's mesothelioma trial results; FDA approval of lower dose of OLUMIANT; Jazz Pharma's phase III TONES 5 study results, and early termination of Sellas' Phase 2b NeuVax study in combination with Herceptin in HER2 1+/2+ breast cancer patients.
FLGT Abuzz, INSY Breathes Easy, NITE Sparkles
Fri, 15 Jun 2018 02:37:19 GMT
The following are some of today's top gainers in the pharma/biotech sector.
Trump Says Russia Should Be Reinstated Into G7
Fri, 08 Jun 2018 14:02:34 GMT
As he prepared to depart for a G7 summit in Canada on Friday, President Donald said Russia should be reinstated into the group of major industrialized countries. Trump told reporters Russia should be at the two-day meeting, arguing that it is important for Russia to be at negotiating table.
Bombardier To De-Cosolidate C-Series Financials On Closing Of Airbus Partnership
Fri, 08 Jun 2018 11:05:40 GMT
Bombardier Inc. (BBD_B.TO, BBD_A.TO), Airbus and Investissement Qu├ębec said on Friday that they have agreed to close the C Series partnership on July 1, 2018. Bombardier said the combination of innovative C Series aircraft would help focus on capturing growth opportunities across the portfolio and delivering remaining turnaround plan objectives.
In The Spotlight: Krystal Biotech
Fri, 08 Jun 2018 09:27:38 GMT
Shares of Krystal Biotech Inc. (KRYS) touched a new high of $13.00 on Thursday, and are up 30% since the beginning of this year.
FDA Nod For EDAP, AGRX Issues Pink Slips, APHB Turns Heads, MNKD Breathes Easy
Fri, 08 Jun 2018 04:47:51 GMT
Today's Daily Dose brings you an update on Agile's corporate business, news on promising results of AmpliPhi's investigational bacteriophage therapeutic AB-SA01; BioMarin's receipt of milestone payments related to breast cancer drug candidate Talazoparib and FDA clearance of EDAP's Focal One device.
MRTX Braces For Busy Year, ADXS Stays Focused, OPHT Inks Gene Therapy Deals
Fri, 08 Jun 2018 00:49:03 GMT
The following are some of today's top gainers in the pharma/biotech sector.
Canada Hits Back With 25% Duty On US Steel Imports
Fri, 01 Jun 2018 15:27:27 GMT
In retaliation to the US Government's decision to impose tariffs on Canadian steel and aluminum shipments, Canada announced the same rate of duties worth C$16.6 billion or $12.8 billion on American imports. Commerce Secretary Wilbur Ross announced Thursday that the U.S. will impose tariffs of 25 percent on steel imports and 10 percent on aluminum imports from Canada, Mexico, and the European Union
Curious to know if Bitcoin is here to stay ?
Mon, 18 Jun 2018 05:45:07 GMT
Read the latest developments from the cryptocurrency space, breaking news and analysis on Bitcoin and blockchain on RTTNews. Know more about altcoins, mining, ICOs, warnings and regulation. Find out how to acquire and trade digital currencies.
Feed Fetched by RSS Dog.